Ling Shi

809 total citations
16 papers, 342 citations indexed

About

Ling Shi is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Reproductive Medicine. According to data from OpenAlex, Ling Shi has authored 16 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 5 papers in Epidemiology and 4 papers in Reproductive Medicine. Recurrent topics in Ling Shi's work include Cardiomyopathy and Myosin Studies (9 papers), Cardiovascular Function and Risk Factors (6 papers) and Congenital Heart Disease Studies (5 papers). Ling Shi is often cited by papers focused on Cardiomyopathy and Myosin Studies (9 papers), Cardiovascular Function and Risk Factors (6 papers) and Congenital Heart Disease Studies (5 papers). Ling Shi collaborates with scholars based in United States, China and Canada. Ling Shi's co-authors include Steven D. Colan, Jeffrey A. Towbin, Charles E. Canter, Carolyn Y. Ho, Mark W. Russell, John L. Jefferies, Mark V. Sherrid, Sharlene M. Day, David A. Bluemke and Hoshang Farhad and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Radiology.

In The Last Decade

Ling Shi

16 papers receiving 332 citations

Peers

Ling Shi

CCM

SURGE

EPIDE

RNMI

Yifei Huang China

Luigi Cappannoli Italy

Michael Schreinlechner Austria

Amadeu Betriu Spain

Trinath Kumar Mishra India

Marco Previtero Italy

Piotr Lodziński Poland

Remco A. J. Schurer Netherlands

Richard Rodeheffer United States

Kayo Hayato Japan

Yifei Huang China

Ling Shi

79 ×0.3

CCM

89 ×1.7

59 ×1.1

SURGE

20 ×0.4

EPIDE

13 ×0.3

RNMI

Citations per year, relative to Ling Shi Ling Shi (= 1×) peers Yifei Huang

Countries citing papers authored by Ling Shi

Since Specialization

Citations

This map shows the geographic impact of Ling Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Shi more than expected).

Fields of papers citing papers by Ling Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Shi. The network helps show where Ling Shi may publish in the future.

Co-authorship network of co-authors of Ling Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Shi. A scholar is included among the top collaborators of Ling Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Shi. Ling Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Kantor, Paul F., Ling Shi, Steven D. Colan, et al.. (2024). Progressive Left Ventricular Remodeling for Predicting Mortality in Children With Dilated Cardiomyopathy: The Pediatric Cardiomyopathy Registry. Journal of the American Heart Association. 13(2). e022557–e022557. 3 indexed citations

Shi, Ling, et al.. (2023). [Electroacupuncture promotes expression of glutathione related regulatory enzymes in ovary tissue of rats with diminished ovarian reserve].. PubMed. 48(4). 378–84. 1 indexed citations

Shi, Ling, Ge Lu, Qian Wang, et al.. (2022). Moxibustion alleviates decreased ovarian reserve in rats by restoring the PI3K/AKT signaling pathway. Journal of Integrative Medicine. 20(2). 163–172. 26 indexed citations

Lu, Ge, Ling Shi, Qian Li, et al.. (2021). Moxibustion Ameliorates Ovarian Reserve in Rats by Mediating Nrf2/HO-1/NLRP3 Anti-Inflammatory Pathway. Evidence-based Complementary and Alternative Medicine. 2021. 1–10. 16 indexed citations

Marceau, Lisa, Rebekah Zincavage, James Ambrosoli, et al.. (2020). Understanding How Clinicians Use a New Web-based Tool for Disseminating Evidence-Based Practices for the Treatment of PTSD: The PTSD Clinicians Exchange. Military Medicine. 185(Supplement_1). 286–295. 1 indexed citations

Rossano, Joseph W., Robert E. Shaddy, Ling Shi, et al.. (2020). Elevated Heart Rate and Survival in Children With Dilated Cardiomyopathy: A Multicenter Study From the Pediatric Cardiomyopathy Registry. Journal of the American Heart Association. 9(15). e015916–e015916. 12 indexed citations

Castleberry, Chesney, John L. Jefferies, Ling Shi, et al.. (2018). No Obesity Paradox in Pediatric Patients With Dilated Cardiomyopathy. JACC Heart Failure. 6(3). 222–230. 16 indexed citations

Vigneault, Davis M., Eunice Yang, Michael Tee, et al.. (2018). Left Ventricular Strain Is Abnormal in Preclinical and Overt Hypertrophic Cardiomyopathy: Cardiac MR Feature Tracking. Radiology. 290(3). 640–648. 62 indexed citations

Singh, Rakesh K., Charles E. Canter, Ling Shi, et al.. (2017). Survival Without Cardiac Transplantation Among Children With Dilated Cardiomyopathy. Journal of the American College of Cardiology. 70(21). 2663–2673. 51 indexed citations

10.

Ho, Carolyn Y., John J.V. McMurray, Allison L. Cirino, et al.. (2017). The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Trial. American Heart Journal. 187. 145–155. 34 indexed citations

11.

Ho, Jennifer E., Ling Shi, Sharlene M. Day, et al.. (2017). Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy. Open Heart. 4(2). e000615–e000615. 23 indexed citations

12.

Feng, Tingting, et al.. (2017). Rhein ameliorates adenomyosis by inhibiting NF-κB and β-Catenin signaling pathway. Biomedicine & Pharmacotherapy. 94. 231–237. 21 indexed citations

13.

Ho, Carolyn Y., Sharlene M. Day, Steven D. Colan, et al.. (2017). The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers. JAMA Cardiology. 2(4). 419–419. 39 indexed citations

14.

Farhad, Hoshang, Sara B. Seidelmann, Davis M. Vigneault, et al.. (2016). Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy. Journal of Cardiovascular Magnetic Resonance. 19(1). 107–107. 33 indexed citations

15.

Lipshultz, Steven E., James D. Wilkinson, Ling Shi, et al.. (2016). THE CARDIAC BIOMARKERS IN CHILDREN WITH CARDIOMYOPATHY MULTICENTER STUDY: PRELIMINARY RESULTS FOR PEDIATRIC HYPERTROPHIC CARDIOMYOPATHY. Journal of the American College of Cardiology. 67(13). 1509–1509. 1 indexed citations

16.

Singh, Rakesh K., Charles E. Canter, Ling Shi, et al.. (2014). Abstract 16801: Improved Transplant-Free Survival of Children With Dilated Cardiomyopathy: Analysis of Two Decades From the Pediatric Cardiomyopathy Registry. Circulation. 130(suppl_2). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact